Stock PPBT PURPLE BIOTECH LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Purple Biotech Ltd

Equities

PPBT

IL0007650166

Biotechnology & Medical Research

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 15:24:05 01/05/2024 BST 		5-day change 1st Jan Change
22.3 ILa +6.19% Intraday chart for Purple Biotech Ltd +10.95% -30.09%
04-25 Purple Biotech Ltd.'s Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting CI
03-14 Purple Biotech Reports Preclinical Proof of Concept for Its Tribody Platform Technology CI

Valuation

Fiscal Period: December 2019 2020 2022 2023 2024 2025 2026
Capitalization 1 14.45 67.11 26.87 21.6 15.51 - -
Enterprise Value (EV) 1 14.45 67.11 26.87 21.6 15.51 15.51 15.51
P/E ratio -2.46 x - - - - - -
Yield - - - - - - -
Capitalization / Revenue - 67.1 x - - - - 2.01 x
EV / Revenue - 67.1 x - - - - 2.01 x
EV / EBITDA - - - - - - -
EV / FCF - - -1.6 x -1.08 x -1.94 x -0.97 x -0.65 x
FCF Yield - - -62.4% -92.3% -51.6% -103% -155%
Price to Book - - - - - - -
Nbr of stocks (in thousands) 19,561 172,106 184,277 244,589 261,132 - -
Reference price 2 0.7389 0.3899 0.1458 0.0883 0.0594 0.0594 0.0594
Announcement Date 11/02/20 02/03/21 08/02/23 05/03/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 1 - - - - - 7.7
EBITDA - - - - - - - -
EBIT 1 - -12.61 - -22.6 -22.27 -18 -25.2 -33.1
Operating Margin - -1,261.2% - - - - - -429.87%
Earnings before Tax (EBT) 1 - - -17.83 - - -13 - -
Net income 1 -5.85 -28 -18.38 - - -13 - -
Net margin - -2,799.9% - - - - - -
EPS -0.3000 - - - - - - -
Free Cash Flow 1 - - - -16.76 -19.93 -8 -16 -24
FCF margin - - - - - - - -311.69%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 11/02/20 02/03/21 09/02/22 08/02/23 05/03/24 - - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - - - - - - - - - - -
EBITDA - - - - - - - - - - -
EBIT 1 - -5.081 -6.601 -5.122 -5.135 -5.747 -6.267 -5.2 -4.7 -4.3 -3.9
Operating Margin - - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - - -
Net income -10.83 - - - - - - - - - -
Net margin - - - - - - - - - - -
EPS -0.0600 - - - - - - - - - -
Dividend per Share - - - - - - - - - - -
Announcement Date 04/08/22 08/11/22 08/02/23 16/05/23 22/08/23 21/11/23 05/03/24 - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - - -16.8 -19.9 -8 -16 -24
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - - - 0.03 0 - - -
Capex / Sales - - - - - - - -
Announcement Date 11/02/20 02/03/21 09/02/22 08/02/23 05/03/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
PURPLE BIOTECH LTD Stock Purple Biotech Ltd
-30.09% 14.94M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.17% 102B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+2.87% 96.09B
ARGENX SE Stock argenx SE
+2.13% 22.28B
BIONTECH SE Stock BioNTech SE
-14.77% 21.4B
GENMAB A/S Stock Genmab A/S
-8.79% 18.14B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.02B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.21% 16.09B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+8.55% 13.83B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.75% 11.97B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. PPBT Stock
  4. Financials Purple Biotech Ltd